Cargando…
Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
Obesity has quickly become a worldwide pandemic, causing major adverse health outcomes such as dyslipidemia, type 2 diabetes mellitus, cardiovascular disease and cancers. Obesity-induced insulin resistance is the key for developing these metabolic disorders, and investigation to understand the molec...
Autores principales: | Kang, Yu Mi, Kim, Francis, Lee, Woo Je |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409001/ https://www.ncbi.nlm.nih.gov/pubmed/28447436 http://dx.doi.org/10.4093/dmj.2017.41.2.89 |
Ejemplares similares
-
The role of vasodilator-stimulated phosphoprotein (VASP) in the control of hepatic gluconeogenic gene expression
por: Tateya, Sanshiro, et al.
Publicado: (2019) -
Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding
por: Tateya, Sanshiro, et al.
Publicado: (2011) -
VASP comet sightings
por: LeBrasseur, Nicole
Publicado: (2004) -
Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer
por: Wang, Ying, et al.
Publicado: (2019) -
Zyxin-VASP interactions alter actin regulatory activity in zyxin-VASP complexes
por: Grange, Jacob, et al.
Publicado: (2012)